Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 pharmaceuticals ranked by total liabilities, at ZAR 2.36T, ahead of Pfizer (ZAR 2.09T) and Johnson & Johnson (ZAR 2.02T). Figures as of 18 Nov 2026, 14:23 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieZAR 2.36T
- Median
- ZAR 35.9B
- Combined market value
- ZAR 88.76T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | ZAR 2.36T | ZAR 8.91T | ZAR 5,038.74 | 0.59% down | 26% up | ||
| 2 | PfizerPFE · Health Care | ZAR 2.09T | ZAR 2.79T | ZAR 489.90 | 1.35% down | 14% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | ZAR 2.02T | ZAR 11.54T | ZAR 4,795.77 | 1.36% down | 38% up | ||
| 4 | Eli LillyLLY · Health Care | ZAR 1.48T | ZAR 21.7T | ZAR 24,358.27 | 1.13% down | 35% up | ||
| 5 | Merck & CoMRK · Health Care | ZAR 1.45T | ZAR 6.08T | ZAR 2,467.06 | 0.75% down | 51% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | ZAR 1.23T | ZAR 2.16T | ZAR 1,055.69 | 2.51% down | 34% up | ||
| 7 | AstraZenecaAZN · Health Care | ZAR 1.12T | ZAR 4.86T | ZAR 3,136.44 | 0.95% down | 2% up | ||
| 8 | NovartisNVS · Health Care | ZAR 1.11T | ZAR 5.17T | ZAR 2,738.25 | 0.67% down | 25% up | ||
| 9 | SanofiSNY · Health Care | ZAR 1.05T | ZAR 1.96T | ZAR 817.88 | 1.78% down | 4% down | ||
| 10 | GSKGSK · Health Care | ZAR 1.03T | ZAR 1.7T | ZAR 847.30 | 2.32% down | 6% up | ||
| 11 | Novo NordiskNVO · Health Care | ZAR 890.8B | ZAR 3.09T | ZAR 700.35 | 2.16% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | ZAR 870.9B | ZAR 1.19T | ZAR 372.37 | 0.23% up | 54% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | ZAR 584.1B | ZAR 3.12T | ZAR 1,801.81 | 2.55% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 565B | ZAR 855.7B | ZAR 733.39 | 0.12% up | 74% up | ||
| 15 | ViatrisVTRS · Health Care | ZAR 386.9B | ZAR 403.4B | ZAR 351.90 | 1.40% down | 96% up | ||
| 16 | GrifolsGRFS · Health Care | ZAR 231.2B | ZAR 101.1B | ZAR 148.50 | 1.15% down | 1% up | ||
| 17 | ZoetisZTS · Health Care | ZAR 208.8B | ZAR 583.7B | ZAR 1,436.49 | 1.08% down | 29% down | ||
| 18 | Royalty PharmaRPRX · Health Care | ZAR 170.5B | ZAR 679.5B | ZAR 1,181.82 | 0.23% up | 78% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 160.1B | ZAR 1.7T | ZAR 16,480.79 | 0.56% up | 36% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 126.3B | ZAR 265.9B | ZAR 4,142.05 | 0.39% up | 37% up | ||
| 21 | GenmabGMAB · Health Care | ZAR 120.9B | ZAR 551.3B | ZAR 894.11 | 0.76% up | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 120.1B | ZAR 2.33T | ZAR 9,192.32 | 0.67% down | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | ZAR 117.2B | ZAR 222.3B | ZAR 444.82 | 2.12% down | 20% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 71.9B | ZAR 360.7B | ZAR 2,693.00 | 2.02% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | ZAR 65.9B | ZAR 812.3B | ZAR 7,111.23 | 0.48% up | 17% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 63.2B | ZAR 126.6B | ZAR 363.43 | 0.52% down | 83% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | ZAR 53.4B | ZAR 86.8B | ZAR 1,038.65 | 1.00% down | 20% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | ZAR 52.2B | ZAR 77.3B | ZAR 463.92 | 3.75% down | 64% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | ZAR 51.8B | ZAR 257.4B | ZAR 1,321.55 | 0.72% down | 17% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 36.4B | ZAR 212.2B | ZAR 254.50 | 0.61% up | 5% up | ||
| 31 | CytokineticsCYTK · Health Care | ZAR 35.9B | ZAR 123.8B | ZAR 888.77 | 2.86% down | 20% down | ||
| 32 | Ascendis PharmaASND · Health Care | ZAR 28B | ZAR 306.1B | ZAR 4,666.54 | 0.20% down | 28% up | ||
| 33 | InsmedINSM · Health Care | ZAR 26.3B | ZAR 460B | ZAR 2,096.92 | 0.83% down | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 25.9B | ZAR 195B | ZAR 1,006.82 | 0.90% up | 11% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 15.2B | ZAR 104.6B | ZAR 739.76 | 2.76% down | 10% up | ||
| 36 | United TherapeuticsUTHR · Health Care | ZAR 13.5B | ZAR 428.1B | ZAR 10,050.98 | 0.64% down | 23% up | ||
| 37 | Legend BiotechLEGN · Health Care | ZAR 12.6B | ZAR 53.8B | ZAR 277.22 | 0.75% up | 42% down | ||
| 38 | AlkermesALKS · Health Care | ZAR 11.5B | ZAR 131.4B | ZAR 782.09 | 2.32% down | 58% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 11.3B | ZAR 168.7B | ZAR 7,261.45 | 0.46% down | 24% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | ZAR 10.4B | ZAR 123.1B | ZAR 2,339.38 | 0.77% down | 7% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | ZAR 9.4B | ZAR 101.1B | ZAR 5,055.78 | 2.62% down | 43% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 9.1B | ZAR 103.3B | ZAR 1,582.24 | 0.40% up | 31% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | ZAR 8.4B | ZAR 84.4B | ZAR 879.31 | 2.82% up | 44% up | ||
| 44 | Roivant SciencesROIV · Health Care | ZAR 7.2B | ZAR 482.6B | ZAR 666.11 | 0.26% up | 90% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | ZAR 7.1B | ZAR 163.1B | ZAR 1,079.09 | 0.08% down | 107% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | ZAR 5.2B | ZAR 83.4B | ZAR 479.23 | 1.49% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 3.6B | ZAR 139.1B | ZAR 2,006.58 | 8.49% up | 13% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 3.4B | ZAR 128.6B | ZAR 1,636.62 | 0.93% up | 126% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | ZAR 3.2B | ZAR 132B | ZAR 1,205.74 | 1.23% up | 8% down | ||
| 50 | ABIVAXABVX · Health Care | ZAR 2.5B | ZAR 123.7B | ZAR 1,412.75 | 1.81% down | 27% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | ZAR 1.9B | ZAR 69.2B | ZAR 505.56 | 2.59% down | 169% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | ZAR 1.6B | ZAR 146.8B | ZAR 183.61 | 9.73% down | 36% down | ||
| 53 | ErascaERAS · Health Care | ZAR 1.2B | ZAR 83.9B | ZAR 239.01 | 8.07% down | 403% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | ZAR 1.1B | ZAR 153.3B | ZAR 1,614.25 | 5.60% down | 286% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | ZAR 1B | ZAR 146.7B | ZAR 5,249.36 | 1.68% down | 61% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | ZAR 920.3M | ZAR 140B | ZAR 2,145.28 | 0.13% down | 46% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | ZAR 645.6M | ZAR 84.3B | ZAR 1,496.72 | 2.87% down | 113% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | ZAR 522.2M | ZAR 79.2B | ZAR 723.41 | 3.75% down | 88% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | ZAR 287.1M | ZAR 112.4B | ZAR 1,657.44 | 2.94% down | 241% up | ||
| 60 | Belite BioBLTE · Health Care | ZAR 173.3M | ZAR 110.2B | ZAR 2,713.99 | 2.98% down | 31% up | ||
| 61 | VeradermicsMANE · Health Care | ZAR 157.6M | ZAR 91.2B | ZAR 2,161.97 | 1.88% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2076 ZAR).
Questions and answers
Which pharmaceuticals rank first by total liabilities?
AbbVie (ZAR 2.36T), Pfizer (ZAR 2.09T) and Johnson & Johnson (ZAR 2.02T) are the top three of the 61 pharmaceuticals ranked by total liabilities as of 18 Nov 2026, 14:23 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of ZAR 88.76T as of 18 Nov 2026, 14:23 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.